A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
In this broadcast by KPCC radio in Los Angeles, California Healthline’s Heidi de Marco reports on the challenges of a daughter caring for her Alzheimer’s-afflicted mother.
Aetna will be the third major insurer to remove prior authorization requirements for patients who seek medication-assisted treatments such as Suboxone.
Trump opponents — and even some supporters — say the election and tumultuous early days of the new administration have left them anxious, angry and afraid of Facebook.
Most veterans who commit suicide do so with a gun, but most therapists don’t understand gun culture. A veteran who has struggled with depression himself now helps bridge that gap by educating mental health professionals.
The number of U.S. Latinos with the memory-robbing disease is expected to rise more than eightfold by 2060, to 3.5 million, according to a recent report — putting a strain on families and health care resources.
Según un informe reciente, se espera que el número de latinos en los Estados Unidos con la enfermedad roba-memoria aumente más de ocho veces para 2060, a 3,5 millones de casos, poniendo presión en las familias y en los recursos de salud.
In an interview with Kaiser Health News, Michael Botticelli outlined his concerns about how GOP efforts to dismantle the health law’s coverage expansions could jeopardize treatment for people in need.
Alzheimer’s researchers hold onto hope after another promising trial ends in disappointment.